Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease

被引:14
作者
Paterson, RLK
Lack, G
Domenico, JM
Delespesse, G
Leung, DYM
Finkel, TH
Gelfand, EW
机构
[1] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV BASIC SCI, DENVER, CO 80206 USA
[2] NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV ALLERGY IMMUNOL, DENVER, CO 80206 USA
[3] UNIV MONTREAL, NOTRE DAME HOSP, MONTREAL, PQ H3C 3J7, CANADA
关键词
CD40; CD23; atopic disease; B cell;
D O I
10.1002/eji.1830260902
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of atopic disease is closely linked to the overproduction of IgE. CD23 and CD40 are two cellular receptors involved in the regulation of IgE production and both receptors are elevated in atopic disease. We have examined the role of CD40 in the regulation of CD23 and soluble CD23 production in healthy and atopic donors. Triggering of the B cell CD40 receptor directly enhances interleukin (IL)-4-mediated up-regulation of CD23 at both the protein and the mRNA level. When atopic donors were studied, the synergistic effect of CD40 triggering on the IL-4-induced up-regulation of CD23 and soluble CD23 (sCD23) was enhanced and there was a relative skewing toward production of sCD23. These studies implicate the CD40 receptor in the hyperproduction of CD23 and sCD23 in atopic disease and suggest that abnormalities may exist in the cellular pathways leading to sCD23 production.
引用
收藏
页码:1979 / 1984
页数:6
相关论文
共 45 条
  • [1] CD21 IS A LIGAND FOR CD23 AND REGULATES IGE PRODUCTION
    AUBRY, JP
    POCHON, S
    GRABER, P
    JANSEN, KU
    BONNEFOY, JY
    [J]. NATURE, 1992, 358 (6386) : 505 - 507
  • [2] CD21 EXPRESSED ON BASOPHILIC CELLS IS INVOLVED IN HISTAMINE-RELEASE TRIGGERED BY CD23 AND ANTI-CD21 ANTIBODIES
    BACON, K
    GAUCHAT, JF
    AUBRY, JP
    POCHON, S
    GRABER, P
    HENCHOZ, S
    BONNEFOY, JY
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) : 2721 - 2724
  • [3] BOURGET I, 1994, J BIOL CHEM, V269, P6927
  • [4] BRODIE C, 1992, J ALLERGY CLIN IMMUN, V89, P324
  • [5] BUJANOWSKIWEBER J, 1989, IMMUNOLOGY, V66, P505
  • [6] SOLUBLE CD23 IS RELEASED BY B-LYMPHOCYTES CYCLING IN RESPONSE TO INTERLEUKIN-4 AND ANTI-BP50 (CDW40)
    CAIRNS, J
    FLORESROMO, L
    MILLSUM, MJ
    GUY, GR
    GILLIS, S
    LEDBETTER, JA
    GORDON, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (03) : 349 - 353
  • [7] CO-CROSS-LINKING FC-EPSILON-RII/CD23 AND B-CELL SURFACE-IMMUNOGLOBULIN MODULATES B-CELL ACTIVATION
    CAMPBELL, KA
    LEES, A
    FINKELMAN, FD
    CONRAD, DH
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) : 2107 - 2112
  • [8] HUMAN RECOMBINANT INTERLEUKIN-4 INDUCES FC-EPSILON RECEPTORS (CD23) ON NORMAL HUMAN LYMPHOCYTES-B
    DEFRANCE, T
    AUBRY, JP
    ROUSSET, F
    VANBERVLIET, B
    BONNEFOY, JY
    ARAI, N
    TAKEBE, Y
    YOKOTA, T
    LEE, F
    ARAI, K
    DEVRIES, J
    BANCHEREAU, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) : 1459 - 1467
  • [9] DELESPESSE G, 1989, J IMMUNOL, V142, P134
  • [10] DELESPESSE G, 1989, CHEM IMMUNOL, V47, P79